Expression profiling of luminal B breast tumor in Indian women

[1]  Anil Kumar,et al.  Breast Cancer Survivorship among Indian Women: An Overview , 2022, Asian Journal of Nursing Education and Research.

[2]  Murad Alahdal,et al.  ANLN and UBE2T are prognostic biomarkers associated with immune regulation in breast cancer: a bioinformatics analysis , 2022, Cancer cell international.

[3]  Prashant Mathur,et al.  Burden of cancers in India - estimates of cancer crude incidence, YLLs, YLDs and DALYs for 2021 and 2025 based on National Cancer Registry Program , 2022, BMC Cancer.

[4]  K. Tsui,et al.  Downregulation of ATP binding cassette subfamily a member 10 acts as a prognostic factor associated with immune infiltration in breast cancer , 2022, Aging.

[5]  Han Yang,et al.  ABCA8 inhibits breast cancer cell proliferation by regulating the AMP activated protein kinase/mammalian target of rapamycin signaling pathway , 2022, Environmental toxicology.

[6]  Qiankun He,et al.  Screening and predicted value of potential biomarkers for breast cancer using bioinformatics analysis , 2021, Scientific Reports.

[7]  Huikun Zhang,et al.  High Expression of Complement Component C7 Indicates Poor Prognosis of Breast Cancer and Is Insensitive to Taxane-Anthracycline Chemotherapy , 2021, Frontiers in Oncology.

[8]  M. Burkard,et al.  High nuclear TPX2 expression correlates with TP53 mutation and poor clinical behavior in a large breast cancer cohort, but is not an independent predictor of chromosomal instability , 2021, BMC Cancer.

[9]  Z. Chang,et al.  Down-Regulation of CIDEA Promoted Tumor Growth and Contributed to Cisplatin Resistance by Regulating the JNK-p21/Bad Signaling Pathways in Esophageal Squamous Cell Carcinoma , 2021, Frontiers in Oncology.

[10]  Jingjing Liu,et al.  Elevated EXO1 expression is associated with breast carcinogenesis and poor prognosis , 2021, Annals of translational medicine.

[11]  F. Ahammad,et al.  A multi-omics approach to reveal the key evidence of GDF10 as a novel therapeutic biomarker for breast cancer , 2020 .

[12]  D. Foran,et al.  Gene expression of adipokines and adipokine receptors in the tumor microenvironment: associations of lower expression with more aggressive breast tumor features , 2020, Breast Cancer Research and Treatment.

[13]  H. Pilch,et al.  Genomic Signatures in Luminal Breast Cancer , 2020, Breast Care.

[14]  Hui Zhang,et al.  ABCC9, NKAPL, and TMEM132C are potential diagnostic and prognostic markers in triple‐negative breast cancer , 2020, Cell biology international.

[15]  G. Nie,et al.  APOBEC3B expression and its prognostic potential in breast cancer , 2020, Oncology letters.

[16]  V. Hervieu,et al.  Loss of Tenascin-X expression during tumor progression: A new pan-cancer marker , 2020, Matrix biology plus.

[17]  Wei Wei,et al.  Identification of differentially expressed lncRNAs and mRNAs in luminal-B breast cancer by RNA-sequencing , 2019, BMC Cancer.

[18]  Shu Zheng,et al.  Significant prognostic values of differentially expressed-aberrantly methylated hub genes in breast cancer , 2019, Journal of Cancer.

[19]  L. Esserman,et al.  Assessment of Long-term Distant Recurrence-Free Survival Associated With Tamoxifen Therapy in Postmenopausal Patients With Luminal A or Luminal B Breast Cancer. , 2019, JAMA oncology.

[20]  Guo Wang,et al.  Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis , 2019, Front. Genet..

[21]  A. Ballestrero,et al.  A new human calpastatin skipped of the inhibitory region protects calpain-1 from inactivation and degradation. , 2019, Biochimica et biophysica acta. Molecular cell research.

[22]  Russell A. Gould,et al.  Calpain 9 as a therapeutic target in TGFβ-induced mesenchymal transition and fibrosis , 2019, Science Translational Medicine.

[23]  Lei Yu,et al.  GDF10 inhibits proliferation and epithelial-mesenchymal transition in triple‐negative breast cancer via upregulation of Smad7 , 2019, Aging.

[24]  Jun Yu,et al.  ERCC6L promotes cell growth and invasion in human colorectal cancer , 2019, Oncology letters.

[25]  P. Arner,et al.  Epigenetic regulation of diabetogenic adipose morphology , 2019, Molecular metabolism.

[26]  Olga Tanaseichuk,et al.  Metascape provides a biologist-oriented resource for the analysis of systems-level datasets , 2019, Nature Communications.

[27]  A. Pandey,et al.  Identification of lncRNAs associated with early‐stage breast cancer and their prognostic implications , 2019, bioRxiv.

[28]  Ailing Zhong,et al.  Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer. , 2018, Biochemical and biophysical research communications.

[29]  Y. Ersoy,et al.  Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation. , 2018, Gene.

[30]  M. Malumbres,et al.  An E2F7-dependent transcriptional program modulates DNA damage repair and genomic stability , 2018, Nucleic acids research.

[31]  Juliana Costa-Silva,et al.  RNA-Seq differential expression analysis: An extended review and a software tool , 2017, PloS one.

[32]  M. Hou,et al.  S100B expression in breast cancer as a predictive marker for cancer metastasis. , 2017, International journal of oncology.

[33]  B. Győrffy,et al.  ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis , 2017, Autophagy.

[34]  P. Thangavelu,et al.  Overexpression of the E2F target gene CENPI promotes chromosome instability and predicts poor prognosis in estrogen receptor-positive breast cancer , 2017, Oncotarget.

[35]  P. Souček,et al.  ABC gene expression profiles have clinical importance and possibly form a new hallmark of cancer , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[36]  Q. Kong,et al.  ERCC6L, a DNA helicase, is involved in cell proliferation and associated with survival and progress in breast and kidney cancers , 2017, Oncotarget.

[37]  F. Pontén,et al.  ANLN is a prognostic biomarker independent of Ki-67 and essential for cell cycle progression in primary breast cancer , 2016, BMC Cancer.

[38]  Á. Rubio,et al.  A large‐scale analysis of alternative splicing reveals a key role of QKI in lung cancer , 2016, Molecular oncology.

[39]  Yujie Liu,et al.  E2F7 overexpression leads to tamoxifen resistance in breast cancer cells by competing with E2F1 at miR-15a/16 promoter , 2015, Oncotarget.

[40]  E. Levanon,et al.  Identification of recurrent regulated alternative splicing events across human solid tumors , 2015, Nucleic acids research.

[41]  Lan Lin,et al.  rMATS: Robust and flexible detection of differential alternative splicing from replicate RNA-Seq data , 2014, Proceedings of the National Academy of Sciences.

[42]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[43]  Gongjun Tan,et al.  Cathepsins mediate tumor metastasis. , 2013, World journal of biological chemistry.

[44]  Wei Shi,et al.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features , 2013, Bioinform..

[45]  Jason B. Nikas,et al.  APOBEC3B is an enzymatic source of mutation in breast cancer , 2013, Nature.

[46]  G. Ball,et al.  Calpastatin is associated with lymphovascular invasion in breast cancer. , 2011, Breast.

[47]  R. Gelber,et al.  Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011 , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[48]  Marcel Martin.  Cutadapt removes adapter sequences from high-throughput sequencing reads , 2011 .

[49]  J. B. Rattner,et al.  Historical perspectives on the discovery and elucidation of autoantibodies to centromere proteins (CENP) and the emerging importance of antibodies to CENP-F. , 2011, Autoimmunity reviews.

[50]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[51]  Charles M. Perou,et al.  Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer , 2009, Journal of the National Cancer Institute.

[52]  Ting Zhang,et al.  Expression of hepaCAM is downregulated in cancers and induces senescence-like growth arrest via a p53/p21-dependent pathway in human breast cancer cells. , 2008, Carcinogenesis.

[53]  Eleni P. Mimitou,et al.  Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing , 2008, Nature.

[54]  T. Katagiri,et al.  Involvement of elevated expression of multiple cell-cycle regulator, DTL/RAMP (denticleless/RA-regulated nuclear matrix associated protein), in the growth of breast cancer cells , 2008, Oncogene.

[55]  S. Baek,et al.  Cytotoxicity of trans-chalcone and licochalcone A against breast cancer cells is due to apoptosis induction and cell cycle arrest. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.